Tag: CORO
CDC Advisers Recommend Pfizer Booster Shot for Children 5 to 11
Third shot can be given at least five months after healthy children complete the two-dose vaccine series
Psychological Distress May Increase Risk for COVID-19 Hospitalization
Depression, worry about COVID-19, loneliness as strongly linked to hospitalization as high cholesterol, hypertension
Rollout of Pfizer COVID-19 Vaccine Saved Lives, Health Care Dollars
Model shows vaccine tied to prevention of 110,000 deaths and a resulting $30.4 billion direct health care cost savings
Preexisting Cardiovascular Conditions Tied to Severe COVID-19 in Children
Risk varies considerably across 26 examined cardiovascular conditions
Loss of Smell, Taste Less Likely With Newer COVID-19 Variants
Lower risk for developing chemosensory loss observed with alpha, delta, and omicron variants
FDA Authorizes Pfizer Booster Shot for Children Ages 5 to 11 Years
Third shot can be given at least five months after healthy children complete the two-dose vaccine series
mRNA-1273 Induces Stronger Response Than BNT162b2 for Immunosuppressed
Findings seen in immunosuppressed patients with rheumatic and musculoskeletal diseases, solid organ transplant recipients
One in Nine Discharged After COVID-19 Admission Die or Are Readmitted
Higher risk seen for patients who were male, had multiple comorbidities and more previous emergency department visits
Vaccine Effectiveness Modest for Children, Teens During Omicron
BNT162b2 vaccine effectiveness against symptomatic infection modest and declined rapidly, was higher after booster dose in teens
AUA: Kidney Transplants From COVID-19-Infected Donors Are Safe
Recipient outcomes similar to kidneys from noninfected donors
